SRS Capital Advisors »

Acasti Pharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3k 500 4.63

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Intermed (INMU)
Spdr Series Trust State Street Spd (TFI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares Us Thema (THRO)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for SRS Capital Advisors

Top funds holding Acasti Pharma

HPM Partners
Nantahala Capital Management
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Jane Street
Renaissance Technologies
Citadel Advisors
Connective Capital Management
Birchview Capital
Diametric Capital
XTX Topco
UBS Group
Kestra Private Wealth Services
Oppenheimer & Co

View all funds holding Acasti Pharma